Physician profile
Sarah Froman
NPI 1215925912
$4,042.65
in general payments reported to CMS, 2019-2025
38 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $566 · 2021: $804 · 2022: $643 · 2023: $978 · 2024: $202 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.61 |
| Education | $273.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $859.54 | 2019-2023 | |
| Astellas Pharma US INC | $669.01 | 2019-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $261.48 | 2019-2022 | |
| Amgen INC. | $224.54 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $195.35 | 2019-2023 | |
| Minerva Surgical, INC | $183.53 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $162.39 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $161.43 | 2021-2023 | |
| Mylan Pharmaceuticals INC. | $148.80 | 2020-2022 | |
| Channel Medsystems, INC. | $120.58 | 2022 | |
| Myovant Sciences INC. | $107.62 | 2021-2022 | |
| Therapeuticsmd, INC. | $92.97 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.61 | 2019-2023 | |
| Conmed Corporation | $87.91 | 2019-2021 | |
| Hologic Sales and Service, LLC | $80.64 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $62.49 | 2019-2020 | |
| Csl Behring | $49.33 | 2023 | Hizentra |
| Sanara Medtech INC. | $45.94 | 2020 | |
| Vertical Pharmaceuticals, LLC | $43.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.51 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $36.86 | 2019-2021 | |
| Becton, Dickinson and Company | $35.74 | 2021 | |
| Heron Therapeutics, INC. | $33.93 | 2022 | |
| Amag Pharmaceuticals, INC. | $32.85 | 2019 | |
| Convatec INC. | $24.65 | 2022 | |
| Abbott Laboratories | $20.42 | 2024 | Freestyle Libre 3 |
| Ethicon US, LLC | $18.88 | 2019 | |
| Meditrina | $17.18 | 2019 | |
| Evofem Biosciences, INC. | $16.63 | 2021 | |
| Roche Diagnostics Corporation | $16.00 | 2019 | |
| Optumhealth Care Solutions, LLC | $14.16 | 2023 | Vivify Health Care Team Portal |
| Medtronic, INC. | $13.88 | 2022 | |
| Exeltis, USA INC. | $13.87 | 2023 | Slynd |
| Duchesnay USA Incorporated | $13.14 | 2019 | |
| Novo Nordisk INC | $12.18 | 2020 | |
| Avion Pharmaceuticals | $11.78 | 2021 | |
| Coopersurgical, INC. | $11.25 | 2021 | |
| Covidien LP | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Froman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.